Brief: Simris Biologics Signs Agreement With Nuvisan
05/06/2025 09:00
June 5 (Reuters) - Simris Group AB SIMRISb.ST: SIMRIS BIOLOGICS SIGNS AGREEMENT WITH NUVISAN FOR IN-VIVO EVALUATION OF NOVEL MICROCYSTIN PAYLOADS Source text: ID:nMFN6TLKkF Further company coverage: [SIMRISb.ST] (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Simris AB
See all newsSweden's Simris Alg Q1 revenue jumps 167%, losses narrow
Brief: Simris Alg Q1 Revenue SEK 424 Thousand
Brief: Simris Group Advances Asset Divestment Process With Two Prospective Buyers
Brief: Simris Evaluating Options To Expand Its ADC-Payload Development Programme
Brief: Simris Updates On Divestment Of Its Assets